Major Program
NCI Community Oncology Research Program
Research Group
Community Oncology and Prevention Trials
Sponsor
University of Rochester NCORP Research Base
Status
Recruiting
NCT ID
NCT05364086
This study compares treatment outcomes between patients of African American/Black (AA) ancestry and European American/White (EA) ancestry currently receiving immune checkpoint inhibitor treatment. Collecting samples of blood and saliva and health and treatment information from racially diverse patients receiving immune checkpoint inhibitor treatment over time may help doctors better understand health care disparities among all cancer patients.
Intervention
Biospecimen Collection, Electronic Health Record Review, Interview, Quality-of-Life Assessment, Questionnaire Administration
Condition
Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm
Investigators
Charles Kamen, PhD, Jay W. Carlson, Bryan A. Faller, Site Public Contact, Alison K. Conlin, Mark A. Taylor, Guilherme Henrique C. Cantuaria, John A. Ellerton, Ahmed I. Megahed, Kathleen Y. Butler, Andrew W. Pippas, Howard M. Gross, Marcus S. Noel, Deimante M. Tamkus, John M. Cho, John E. Doster, Stephen H. Dyar, Rajasree P. Chowdry, Suparna Mantha, Alyssa Mader, Philip E. Lammers, Raed Al-Rajabi, Ki Y. Chung, Tareq Al baghdadi, Michael Humeniuk, Jennifer L. Heaberlin, Sarah E. Jax, Kamal Kant Singh Abbi, Sharad A. Ghamande, Samuel N. Ofori, Daniel Johnson, Albert C. Lockhart, Charles S. Kuzma, Victor T. Lin, Gregory A. Masters, Charles Kamen, Gary V. Burton, Igor Puzanov, Apurva N. Shah, Alexander Menter, William J. Irvin, Brian L. Burnette, Marshall P. Stagg, Jennifer M. Suga, Luiz O. Pita De Oliveira
CT Research Area
Symptom Science